LifeVantage Statistics
Total Valuation
LifeVantage has a market cap or net worth of $76.70 million. The enterprise value is $78.59 million.
| Market Cap | 76.70M |
| Enterprise Value | 78.59M |
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | Jun 1, 2026 |
Share Statistics
LifeVantage has 12.62 million shares outstanding. The number of shares has decreased by -1.17% in one year.
| Current Share Class | 12.62M |
| Shares Outstanding | 12.62M |
| Shares Change (YoY) | -1.17% |
| Shares Change (QoQ) | -0.67% |
| Owned by Insiders (%) | 16.27% |
| Owned by Institutions (%) | 53.99% |
| Float | 8.95M |
Valuation Ratios
The trailing PE ratio is 13.49 and the forward PE ratio is 16.81.
| PE Ratio | 13.49 |
| Forward PE | 16.81 |
| PS Ratio | 0.41 |
| Forward PS | 0.46 |
| PB Ratio | 2.42 |
| P/TBV Ratio | 2.72 |
| P/FCF Ratio | 21.42 |
| P/OCF Ratio | 12.43 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.85, with an EV/FCF ratio of 20.82.
| EV / Earnings | 13.66 |
| EV / Sales | 0.40 |
| EV / EBITDA | 7.85 |
| EV / EBIT | 10.94 |
| EV / FCF | 20.82 |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.96 |
| Quick Ratio | 0.85 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 0.86 |
| Debt / FCF | 2.70 |
| Interest Coverage | 149.60 |
Financial Efficiency
Return on equity (ROE) is 17.08% and return on invested capital (ROIC) is 18.91%.
| Return on Equity (ROE) | 17.08% |
| Return on Assets (ROA) | 6.44% |
| Return on Invested Capital (ROIC) | 18.91% |
| Return on Capital Employed (ROCE) | 17.09% |
| Weighted Average Cost of Capital (WACC) | 7.38% |
| Revenue Per Employee | $820,685 |
| Profits Per Employee | $24,168 |
| Employee Count | 238 |
| Asset Turnover | 2.80 |
| Inventory Turnover | 2.10 |
Taxes
In the past 12 months, LifeVantage has paid $1.01 million in taxes.
| Income Tax | 1.01M |
| Effective Tax Rate | 14.99% |
Stock Price Statistics
The stock price has decreased by -51.48% in the last 52 weeks. The beta is 0.73, so LifeVantage's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -51.48% |
| 50-Day Moving Average | 6.25 |
| 200-Day Moving Average | 6.69 |
| Relative Strength Index (RSI) | 41.71 |
| Average Volume (20 Days) | 966,553 |
Short Selling Information
The latest short interest is 3.54 million, so 28.09% of the outstanding shares have been sold short.
| Short Interest | 3.54M |
| Short Previous Month | 3.59M |
| Short % of Shares Out | 28.09% |
| Short % of Float | 39.62% |
| Short Ratio (days to cover) | 12.01 |
Income Statement
In the last 12 months, LifeVantage had revenue of $195.32 million and earned $5.75 million in profits. Earnings per share was $0.45.
| Revenue | 195.32M |
| Gross Profit | 152.62M |
| Operating Income | 7.18M |
| Pretax Income | 6.77M |
| Net Income | 5.75M |
| EBITDA | 10.01M |
| EBIT | 7.18M |
| Earnings Per Share (EPS) | $0.45 |
Balance Sheet
The company has $12.48 million in cash and $10.21 million in debt, with a net cash position of $2.28 million or $0.18 per share.
| Cash & Cash Equivalents | 12.48M |
| Total Debt | 10.21M |
| Net Cash | 2.28M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | 33.34M |
| Book Value Per Share | 2.64 |
| Working Capital | 19.21M |
Cash Flow
In the last 12 months, operating cash flow was $6.51 million and capital expenditures -$2.73 million, giving a free cash flow of $3.78 million.
| Operating Cash Flow | 6.51M |
| Capital Expenditures | -2.73M |
| Depreciation & Amortization | 2.83M |
| Net Borrowing | n/a |
| Free Cash Flow | 3.78M |
| FCF Per Share | $0.30 |
Margins
Gross margin is 78.14%, with operating and profit margins of 3.68% and 2.94%.
| Gross Margin | 78.14% |
| Operating Margin | 3.68% |
| Pretax Margin | 3.46% |
| Profit Margin | 2.94% |
| EBITDA Margin | 5.12% |
| EBIT Margin | 3.68% |
| FCF Margin | 1.93% |
Dividends & Yields
This stock pays an annual dividend of $0.18, which amounts to a dividend yield of 2.96%.
| Dividend Per Share | $0.18 |
| Dividend Yield | 2.96% |
| Dividend Growth (YoY) | 12.12% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 41.05% |
| Buyback Yield | 1.17% |
| Shareholder Yield | 3.97% |
| Earnings Yield | 7.11% |
| FCF Yield | 4.67% |
Analyst Forecast
The average price target for LifeVantage is $7.00, which is 15.13% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.00 |
| Price Target Difference | 15.13% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -10.23% |
| EPS Growth Forecast (3Y) | -20.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 19, 2015. It was a reverse split with a ratio of 1:7.
| Last Split Date | Oct 19, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
LifeVantage has an Altman Z-Score of 4.08 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.08 |
| Piotroski F-Score | 5 |